Freeze-Drying Techniques for Nanoparticle Stabilization

Freeze-drying, or lyophilization, is a critical post-processing step to convert liquid nanoparticle suspensions into stable, dry powders. The process comprises three main stages: controlled freezing to form ice crystals, primary drying under reduced pressure to sublimate ice, and secondary drying to desorb unfrozen water. Proper selection of cryo- and lyoprotectants—such as disaccharides, polymers or amino acids—enables the water replacement and vitrification mechanisms that preserve nanoparticle morphology, prevent aggregation and minimise cargo leakage. Across lipid-based systems (liposomes, solid lipid nanoparticles and lipid nanoparticles), polymeric nanocapsules and extracellular vesicles, optimising freezing rate, shelf temperature and chamber pressure is essential to control ice crystal size and to mitigate shear and osmotic stresses. The resulting powders offer extended shelf life at ambient temperature, simplified transport and improved accessibility for point-of-care applications, reducing reliance on cold-chain infrastructure. Freeze-drying also facilitates reconstitution into injectable or inhalable formulations for vaccination, targeted drug delivery and biologic therapies. Despite these advantages, challenges remain in scaling up processes, ensuring batch uniformity and maintaining functional integrity of sensitive cargos such as mRNA or monoclonal antibodies. Ongoing efforts seek to refine excipient combinations, tailor freeze-drying cycles and develop advanced analytical methods to monitor structure and stability throughout the process.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Research from all publishers

Recent studies on extracellular vesicle lyophilization have demonstrated that careful control of freezing kinetics and selection of cryoprotectants significantly enhance vesicle stability at room temperature. By investigating parameters such as cooling rate and protectant concentration, researchers achieved powders that maintain vesicle size distribution and biological activity upon reconstitution, thereby improving the feasibility of point-of-care therapeutic delivery without cold storage.

In lipid nanoparticle systems for mRNA vaccines, a straightforward freeze-drying protocol has been shown to yield dry powder formulations that preserve key physicochemical properties after storage at 4 °C. To counteract the disruptive shear forces generated during ice formation, formulations replacing cholesterol with β-sitosterol and incorporating fusogenic phospholipids maintained transfection efficiency in vitro and in vivo. Intratracheal administration of reconstituted powders elicited robust mucosal and systemic immune responses, highlighting their potential for pulmonary vaccine delivery.

Polymeric nanocapsules have been lyophilized to address intrinsic instability sources such as core-shell separation and polymer degradation. Systematic evaluation of formulation variables—polymer composition, protectant identity and concentration—and process parameters has elucidated the relationships between glass transition temperatures, residual moisture and post-drying redispersibility. Advanced characterisation techniques, including differential scanning calorimetry and electron microscopy, provide insight into the microstructural changes that dictate shelf stability and reconstitution performance.

Freeze-Drying Techniques for Nanoparticle Stabilization publication trend

The graph below shows the total number of articles in freeze-drying techniques for nanoparticle stabilization across all publications each year (not limited to Nature Index journals).

Technical terms

Lyophilization (freeze-drying): A dehydration process involving freezing, primary sublimation and secondary desorption under vacuum to produce stable dry powders.

Cryoprotectant/Lyoprotectant: A compound (e.g. trehalose, mannitol, polymers) that stabilises nanoparticles by inhibiting ice crystal damage and forming a glassy matrix.

Polydispersity Index (PDI): A dimensionless measure of particle size distribution; lower values indicate a more uniform population.

Glass Transition Temperature (Tg′): The temperature at which an amorphous system transforms into a glassy state, critical for determining drying conditions.

Vitrification: The formation of an amorphous, glass-like solid during freezing that immobilises solutes and protects nanoparticle architecture.

References

1. Extracellular vesicle lyophilization for enhanced distribution to the point of care. Extracellular Vesicle (2024).
2. Design, optimization, and evaluation of lyophilized lipid nanoparticles for mRNA-based pulmonary mucosal vaccination. Materials Today Bio (2025).
3. Lyophilization of Nanocapsules: Instability Sources, Formulation and Process Parameters. Pharmaceutics (2021).